CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities:
Net Income (Loss)	$ 33,344	$ (4,358)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	3,909	1,793
Stock-based compensation	11,790	10,224
Restructuring equity modification expense	366
Accretion of discount or amortization of premium on investments	(67)	(766)
Amortization of debt issuance costs	407	400
Deferred tax expense	(278)
Revaluation of acquisition-related contingent consideration liability	907
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable	(4,503)	(10,970)
Inventory	9,400	(39,412)
Prepaid expenses and other assets	1,355	1,389
Accounts payable	1,878	14,650
Accrued compensation and employee related benefits	(292)	(2,006)
Accrued and other liabilities	2,182	4,472
Operating lease right-of-use assets	614	695
Operating lease liabilities	(820)	(891)
Deferred revenue	(52)	(1,780)
Net cash provided by (used in) operating activities	60,140	(26,560)
Investing activities:
Proceeds from sales of investments		13,372
Proceeds from maturities of investments	11,248	34,136
Purchases of property and equipment	(6,202)	(7,582)
Net cash provided by investing activities	5,046	39,926
Financing activities:
Proceeds from exercise of stock options and employee stock purchase plan	6,917	4,520
Net cash provided by financing activities	6,917	4,520
Effect of exchange rate changes on cash and cash equivalents	(44)
Net increase in cash and cash equivalents	72,059	17,886
Cash and cash equivalents
Beginning of period	94,793	19,597
End of period	166,852	37,483
Supplemental disclosure of cashflow information:
Purchases of property and equipment not yet paid	299	$ 3,284
Acquisition-related contingent consideration liability	$ 7,087